- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
- Locations
-
- Investigator site 2 - US0010032 Carlsbad, California, United States
- Investigator Site 41 - US0010004 Orange, California, United States
- Investigator site 2 - US0010108 Boca Raton, Florida, United States
- Investigator site 1 - US0010110 Port Charlotte, Florida, United States
Clinical trial condition
Generalized Myasthenia Gravis
Explore clinical trials studying Generalized Myasthenia Gravis. Study availability and eligibility vary by location and protocol.
51 public trials
21 recruiting studies
Generalized Myasthenia Gravis trial results
NCT03315130
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
- Locations
-
- Diagnostic and Medical Clinic - Mobile Mobile, Alabama, United States
- The Research Center of Southern California Carlsbad, California, United States
- UCLA Medical Center Los Angeles, California, United States
- University of California Irvine Health ALS and Neuromuscular Center Orange, California, United States
NCT03669588
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
- Locations
-
- Investigator Site 29 Phoenix, Arizona, United States
- Investigator Site 66 Carlsbad, California, United States
- Investigator Site 5 Los Angeles, California, United States
- Investigator Site 49 Los Angeles, California, United States
NCT00515450
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
- Locations
-
- Nagasaki University Nagasaki, Japan
Active, Not Recruiting
Open-Label Extension of Zilucoplan in Subjects With Generalized Myasthenia Gravis
NCT04225871
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
- Locations
-
- Mg0011 41 Mobile, Alabama, United States
- Mg0011 116 Phoenix, Arizona, United States
- Mg0011 31 Irvine, California, United States
- MG0011 4 Los Angeles, California, United States
Active, Not Recruiting
A Study of Rozanolixizumab in Pediatric Study Participants With Moderate to Severe Generalized Myasthenia Gravis
NCT06149559
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
- Locations
-
- Mg0006 40290 Bologna, Italy
- Mg0006 40144 Milan, Italy
- Mg0006 40733 Naples, Italy
- Mg0006 20340 Fuchu-shi, Japan
Active, Not Recruiting
A Study to Test How Safe Pozelimab and Cemdisiran Combination Therapy and Cemdisiran Alone Are and How Well They Work in Adult Patients With Generalized Myasthenia Gravis
NCT05070858
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
- Locations
-
- HonorHealth Neurology 2018 Scottsdale, Arizona, United States
- University of California Irvine Irvine, California, United States
- University of Southern California Los Angeles, California, United States
- Colorado Springs Neurological Associates Colorado Springs, Colorado, United States
Active, Not Recruiting
Safety and Efficacy of ALXN1720 in Adults With Generalized Myasthenia Gravis
NCT05556096
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
- Locations
-
- Research Site Orange, California, United States
- Research Site Fort Collins, Colorado, United States
- Research Site Washington D.C., District of Columbia, United States
- Research Site Bradenton, Florida, United States
Active, Not Recruiting
Phase 3 Study to Assess the Efficacy and Safety of Batoclimab as Induction and Maintenance Therapy in Adult Participants With Generalized Myasthenia Gravis
NCT05403541
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
- Locations
-
- Site Number -1022 Phoenix, Arizona, United States
- Site Number -1029 Scottsdale, Arizona, United States
- Site Number -1002 Carlsbad, California, United States
- Site Number -1009 Irvine, California, United States
Active, Not Recruiting
Evaluation of PK, PD, Efficacy, Safety, and Immunogenicity of IV Ravulizumab in Pediatric Participants With Generalized Myasthenia Gravis
NCT05644561
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +12 more
- Locations
-
- Research Site Los Angeles, California, United States
- Research Site Boston, Massachusetts, United States
- Research Site Chapel Hill, North Carolina, United States
- Research Site Philadelphia, Pennsylvania, United States